TTRV30M oligomeric aggregates inhibit proliferation of renal progenitor cells b...

• Autor(es): Moreira, L. ; Ballerini, L. ; Peired, A. ; Sagrinati, C. ; Parente, E. ; Angelotti, M.L. ; Ronconi, E. ; Lazzeri, E. ; Mazzinghi, B. ; Lacerda, P. ; Beirão, I. ; Lasagni, L. ; Costa, P.P. ; Romagnani, P.
• Data: 2012
• Identificador Persistente: http://hdl.handle.net/10400.18/2207
• Origem: Repositório Científico do Instituto Nacional de Saúde
• Assunto(s): Familial Amyloidotic Polyneuropathy; Transthyretin; Renal Progenitor Cells; Renal Disease; Doenças Genéticas
• Tipo de Documento: Documento de conferência
• Idioma: Inglês

Descrição

Publicado em: The Proceedings of the XIIIth International Symposium on Amyloidosis, May 6-10, 2012, Groningen, The Netherlands In Familial Amyloidotic Polyneuropathy, the amyloid deposition of mutant transthyretin TTR V30M can lead to renal complications. An unexplored mechanism is the toxicity of oligomeric TTR aggregates. A subset of renal progenitor cells (RPC) in the adult human kidney can induce regeneration of podocytes and tubular structures of the nephron, which can be critical for preventing irreversible renal failure. We assessed whether RPC are vulnerable, in vitro, to TTRV30M oligomers. RPC proliferation was reduced by 16.3±9.7% and 32.6±6.3% after 48 and 72 hours, respectively, in the presence of the oligomers. However, oligomers did not induce apoptosis or alterations in cell cycle to any significant extent, and did not influence RPC differentiation into podocytes. From this first attempt, we can say that TTRV30M oligomers inhibit RPC proliferation but do not influence their capacity to differentiate into mature podocytes, and thus should not compromise tissue regeneration.